CONTRACT NOTICE – OFFICIAL JOURNAL
|
Section I: Contracting Authority
|
I.1)
|
Name, Address and Contact Point(s)
|
|
Hertfordshire NHS Procurement |
Hertfordshire NHS Procurement-Gate, Gate House, Fretherne Rd |
Welwyn Garden City |
AL8 6NS |
UK |
Miss Emma Lavell |
+44 1707356177 |
emma.lavell@hertsprocurement.nhs.uk |
|
|
|
|
|

 |
|

 |
|

 |
|
I.2)
|
Type of contracting Authority and Main Activity or Activities
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
|
No |
Section II: Object of the Contract
|
II.1)
|
Description
|
II.1.1)
|
Title attributed to the contract by the contracting authoritySupply to East and North Hertfordshire NHS Trust with Provision of an Aseptic reconstitution service for parenteral anti-cancer therapy including clinical trials drugs and vaccines. |
II.1.2(a))
|
Type of works contract
|
II.1.2(b))
|
Type of supplies contract
|
II.1.2(c))
|
Type of service contract27 |
II.1.2)
|
Main site or location of works, place of delivery or performance
East & North Hertfordshire NHS Trust, Mount Vernon Hospital, Rickmansworth Rd, Northwood, Middlesex, HA6 2RN, Lister Hospital, Coreys Mill Lane, Stevenage, Hertfordshire, SG1 4AB.
UKH23 |
II.1.3)
|
This notice involves
|
 |
|
 |
|
 |
|
II.1.4)
|
Information on framework agreement (if applicable)
|
 |
|
 |
|
|
Number of participants to the framework agreement envisaged
|
|
Duration of the framework agreement
|
|
Justification for a framework agreement the duration of which exceeds four years
|
|
Estimated total value of purchases for the entire duration of the framework agreement
|
|
Frequency and value of the contracts to be awarded |
II.1.5)
|
Short description of the contract or purchase(s)
East & North Herts NHS Trust runs an established chemotherapy service at the Mount Vernon Cancer Centre and the Lister Hospital.
This service involves the treatment of patients with both oral and parenteral anti-cancer therapy including vaccines.
Both sites are dedicated to research and development and participate in a wide variety of clinical trials.
We are looking to enter into a contract with a supplier for the provision of a reconstitution service for parenteral anti-cancer therapy including undertaking in conjunction with the Trust clinical trials drugs and vaccines. We require a supplier who will act in partnership with the Trust as the service evolves and develops. The supplier will need to provide excellent reliability to support clinical services, and demonstrate that they are able to deliver a service in line with the latest developments in the field over the expected life of the contract to be awarded. The Trust is intending to award a contract for an initial term of 3 years with options, exercisable by the Trust, to extend the contract term for two additional periods of 1 year each.
|
II.1.6)
|
Common Procurement Vocabulary (CPV)
|
|
|
|
85149000 |
|
|
|
|
|
II.1.7)
|
Contract covered by the Government Procurement Agreement (GPA) |
II.1.8)
|
Division into lots Yes
|
 |
|
 |
|
 |
|
II.1.9)
|
Will variants be accepted
No |
II.2)
|
Quantity or Scope of the Contract
|
II.2.1)
|
Total quantity or scopePatient Specific SACT — GBP 7,208,598 per annum.
Dose Banded SACT — GBP 145,776 per annum.
Clinical Trials — GBP 308,928 per annum. |
|
30 000 00035 000 000 GBP |
II.2.2)
|
Options |
|
Provisional timetable for recourse to these options
|
|
Number of possible renewals
|
|
In the case of renewable supplies or service contracts, estimated time frame for subsequent contracts
|
II.3)
|
Duration of the contract or limit for completion36 |
Section III: Legal, Economic, Financial and Technical Information
|
Section IV: Procedure
|
IV.1)
|
Type of Procedure
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
Justification for the choice of accelerated procedure
|
IV.1.1)
|
Have candidates already been selected? No |
IV.1.2)
|
Limitations on the number of operators who will be invited to tender or to participate |
|
|
Objective criteria for choosing the limited number of candidates
|
IV.1.3)
|
Reduction of the number of operators during the negotiation or dialogue
|
 |
|
IV.3 Administrative Information
|
IV.3.1)
|
Reference number attributed to the notice by the contracting authority
|
IV.3.2)
|
Previous publication(s) concerning the same contract
|
 |
|
 |
Other previous publications
|
IV.3.3)
|
Conditions for obtaining specifications and additional documents
|
IV.3.4)
|
Time-limit for receipt of tenders or requests to participate 12-09-2014
12:00 |
IV.3.5)
|
Date of dispatch of invitations to tender or to participate to selected candidates
|
IV.3.6)
|
Language or languages in which tenders or requests to participate can be drawn up
|
IV.3.7)
|
Minimum time frame during which the tenderer must maintain the tender
|
IV.3.8)
|
Conditions for opening tenders
|
|
|
|
|
Section VI: Other Information
|
VI.1)
|
Indicate whether this procurement is a recurrent one and the Estimated timing for further notices to be published
|
VI.2)
|
Does the contract relate to a Project/Programme financed by Community Funds? No
|
VI.3)
|
Additional Information
|
VI.4)
|
Procedures for appeal
|
VI.4.1)
|
Body responsible for appeal procedures
|
|
|
|
|
|
|
|
|
|
|
|
Body responsible for mediation procedures
|
|
|
|
|
|
|
|
|
|
VI.4.2)
|
Lodging of appeals
|
VI.4.3)
|
Service from which information about the lodging of appeals may be obtained
|
|
|
|
|
|
|
|
|
|
VI.5)
|
Dispatch date of this Notice 11-08-2014 |
ANNEX A
Additional Addresses and Contact Points
|
I)
|
Address and contact points from which further information can be obtained
Via Due North Portal |
|
|
|
|
|
|
|
|
|
|
II)
|
Address and contact points from which specifications and additional documentation may be obtained
Via Due North Portal |
This will be part of the final ITT. |
|
|
|
|
|
|
|
|
|
III)
|
Address and contact points to which Tenders/Requests to Participate must be sent
Via Due North Portal |
|
|
|
|
|
|
|
|
|
|
|
ANNEX B
Information About Lots
|
| 1
Banded Drugs |
1)
|
Short Description
|
2)
|
Common Procurement Vocabulary (CPV)
|
|
|
|
85149000 |
|
|
|
|
|
3)
|
Quantity or scope
|
4)
|
Indication about different contract dates
|
5)
|
Additional Information about lots
|
ANNEX B
Information About Lots
|
| 2
Patient Specific |
1)
|
Short Description
|
2)
|
Common Procurement Vocabulary (CPV)
|
|
|
|
85149000 |
|
|
|
|
|
3)
|
Quantity or scope
|
4)
|
Indication about different contract dates
|
5)
|
Additional Information about lots
|
ANNEX B
Information About Lots
|
| 3
Clinical Trials |
1)
|
Short Description
|
2)
|
Common Procurement Vocabulary (CPV)
|
|
|
|
85149000 |
|
|
|
|
|
3)
|
Quantity or scope
|
4)
|
Indication about different contract dates
|
5)
|
Additional Information about lots
|
|